81307 Palb2 gene full gene seq
Also known as: PALB2 full sequencing, breast ovarian cancer genetic test
Partner and Localizer of Breakpoint Containing 2 (PALB2) gene full gene sequence analysis to identify breast and ovarian cancer predisposition variants.
In Plain Language
Hereditary breast cancer test; Ovarian cancer predisposition screening
Clinical Context
Full PALB2 sequencing for hereditary breast and ovarian cancer diagnosis in high-risk families, particularly those negative for BRCA1/2.
RVU Information
CPT 81307 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81307?
CPT 81307 (Palb2 gene full gene seq) is a Pathology & Lab code. Partner and Localizer of Breakpoint Containing 2 (PALB2) gene full gene sequence analysis to identify breast and ovarian cancer predisposition variants.
Who uses CPT code 81307?
CPT 81307 is used by Pathology, Oncology, Genetics. Full PALB2 sequencing for hereditary breast and ovarian cancer diagnosis in high-risk families, particularly those negative for BRCA1/2.
When is CPT 81307 used?
Full PALB2 sequencing for hereditary breast and ovarian cancer diagnosis in high-risk families, particularly those negative for BRCA1/2.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.